Monday, February 16, 2026 | 03:45 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sohini Das

Sohini Das

Sohini Das

Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.

Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.

Email
Twitter
LinkedIn

Page 24 - Sohini Das

Monsoon brings fever season to India; Kerala, Karnataka see Dengue spike

More than 10,000 cases of dengue, including eight fatal cases, have been reported so far this year in the adjacent state of Karnataka

Monsoon brings fever season to India; Kerala, Karnataka see Dengue spike
Updated On : 19 Jul 2024 | 10:08 PM IST

US Biosecure Act spells long-term boost for Indian CDMO, CRO firms

As American biopharma looks to diversify sourcing, Indian companies stand to benefit

US Biosecure Act spells long-term boost for Indian CDMO, CRO firms
Updated On : 19 Jul 2024 | 6:57 PM IST

Bajaj Auto Q1 PAT up 18% at Rs 1,941.79 cr on double digit revenue growth

The revenue from operations grew due to strong vehicle sales, record revenue from spares, and volume expansion across both domestic and export businesses

Bajaj Auto Q1 PAT up 18% at Rs 1,941.79 cr on double digit revenue growth
Updated On : 16 Jul 2024 | 11:43 PM IST

Lupin divests women's health specialty biz in US to Evofem Biosciences

Company says divestment aligns US specialty business with therapeutic areas like respiratory, neurology

Lupin divests women's health specialty biz in US to Evofem Biosciences
Updated On : 15 Jul 2024 | 8:24 PM IST

Q1 results preview: Niche US products, domestic growth may boost pharma biz

Brokerages expect aggregate sales growth of 11 per cent, and 21 per cent earnings growth during this period

Q1 results preview: Niche US products, domestic growth may boost pharma biz
Updated On : 14 Jul 2024 | 11:03 PM IST

Two-wheeler volume growth likely to drive profit for auto sector in Q1

OEMs may post 9-10% revenue growth for June quarter

Two-wheeler volume growth likely to drive profit for auto sector in Q1
Updated On : 14 Jul 2024 | 10:59 PM IST

Antidiabetic drug Semaglutide linked to potential vision loss: Study

Researchers say future study required to assess causality

Antidiabetic drug Semaglutide linked to potential vision loss: Study
Updated On : 14 Jul 2024 | 10:13 PM IST

Vidyut launches offline pre-owned EV sales and financing platform

The company also plans to launch an online marketplace in the next six months to reach a wider audience

Vidyut launches offline pre-owned EV sales and financing platform
Updated On : 11 Jul 2024 | 7:34 PM IST

After launch of Bajaj Freedom 125, TVS may roll out its own CNG bike

The CNG fuel option in the commuter segment offers a reduced fuel bill for the consumer

After launch of Bajaj Freedom 125, TVS may roll out its own CNG bike
Updated On : 10 Jul 2024 | 11:52 PM IST

M&HCV, bus sales shift up in Q1; top 4 companies register 7.2 growth

H2FY25 expected to see demand revival as monsoons end; H1 affected by elections

M&HCV, bus sales shift up in Q1; top 4 companies register 7.2 growth
Updated On : 10 Jul 2024 | 11:48 PM IST

Honda two-wheeler share increases after on-board norms compliance

Sales gap with Hero narrows to 45,000 units in June

Honda two-wheeler share increases after on-board norms compliance
Updated On : 09 Jul 2024 | 10:40 PM IST

Sun Pharma open to exploring acquisitions in global specialty portfolio

Sun Pharma has net cash position of $2.4 bn at end of FY24; 6 new specialty products in R&D pipeline

Sun Pharma open to exploring acquisitions in global specialty portfolio
Updated On : 08 Jul 2024 | 10:47 PM IST

Mercedes looks to charge up India play, posts 60% rise in battery EV sales

The company launched the EQA 250+ on Monday, priced at Rs 66 lakh, which comes with a range of 497-560 km per charge

Mercedes looks to charge up India play, posts 60% rise in battery EV sales
Updated On : 08 Jul 2024 | 10:09 PM IST

Bajaj Auto strikes 'Tiger Zinda Hai' note as first CNG bike hits the road

Bajaj Auto launches world's first CNG-powered bike Freedom 125 at Rs 95k

Bajaj Auto strikes 'Tiger Zinda Hai' note as first CNG bike hits the road
Updated On : 05 Jul 2024 | 11:32 PM IST

Bajaj Auto set to launch world's first CNG bike 'Freedom 125' on Friday

The bike is likely to have flexible fuel options and will feature two separate switches for petrol and CNG

Bajaj Auto set to launch world's first CNG bike 'Freedom 125' on Friday
Updated On : 04 Jul 2024 | 10:12 PM IST

India's medical tourism gets booster shot from Bangladesh visitors

During the general elections, however, there has been a temporary lull in patients from Bangladesh as well as less visas were issued

India's medical tourism gets booster shot from Bangladesh visitors
Updated On : 02 Jul 2024 | 12:38 AM IST

The tweet that built Bujji, Jayem Auto's 6-tonne beast for Kalki 2898 AD

The concept of this car which has three large wheels and runs on an electric propulsion system powered by a 47 kWh battery pack started about two years back

The tweet that built Bujji, Jayem Auto's 6-tonne beast for Kalki 2898 AD
Updated On : 30 Jun 2024 | 10:27 PM IST

Mumbai-based Wockhardt to launch its novel antibiotic Zaynich by FY25-end

Global launch in FY26 after multinational clinical trial ends

Mumbai-based Wockhardt to launch its novel antibiotic Zaynich by FY25-end
Updated On : 28 Jun 2024 | 11:31 PM IST

Emcure Pharma seeks to raise Rs 1,952 cr through IPO, issue opens July 3

Fourth largest IPO of 2024; company will use the proceeds to repay debt and for general corporate purposes

Emcure Pharma seeks to raise Rs 1,952 cr through IPO, issue opens July 3
Updated On : 28 Jun 2024 | 11:05 PM IST

India to make Ozempic-like drugs for diabetes, obesity under PLI by 2026

GLP-1RA works by activating GLP-1 receptors in the pancreas, which leads to enhanced insulin release and reduced glucagon release responses

India to make Ozempic-like drugs for diabetes, obesity under PLI by 2026
Updated On : 28 Jun 2024 | 10:27 AM IST